Skip to main content
Please enable JS
ferrer 4 future
Building a healthier society through digital technologies
Ferrer 4 Future
Ferrer 4 Future
Ferrer
4 Future

An open innovation program that aims to empower entrepreneurs and digital health businesses to develop disruptive health solutions through the use of digital technologies.

What is Ferrer 4 Future Program?

What is Ferrer 4 Future Program?

We at Ferrer believe that digital health is about putting patient’s needs first and developing digital solutions across the patient care value chain (physicians, caregivers, payers, hospitals and so on) to address those needs in a manner that enhances the patient’s human experience. We also recognize that the knowledge and experience of pharma companies needs to be balanced with the creativity and agility of start-ups and small businesses.

Through Ferrer 4 Future program, we aim to create a platform for collaboration between start ups and us to explore digital health solutions together that can build healthier societies.

Who are we looking for?

Who are we looking for?

Passion

Passion

You are passionate about disrupting the health industry using digital technologies.

Need

Need

You are addressing a real and verified need.

Focus

Focus

You are focused on Central Nervous System, Cardio-metabolism, Pain, Gastro-intestinal or Oncology (other therapeutic areas will also be considered).

Health

Health

You are developing solutions for patients who are ill or suffering from illness related disabilities (i.e. not wellness).

What are you waiting for?
The deadline for application to the challenges ends on the 20th December at 11:59 a.m
0
days
0
hours
0
minutes
What are you waiting for?
The deadline for application to the challenges ends on the 20th December at 11:59 a.m
0
days
0
hours
0
minutes
Challenge 1
Enhance care for chronic patients
Chronic patients dependent on home support often find their freedoms restricted.
For example, PAH (Pulmonary Arterial Hypertension) patients progressively see their mobility curbing and their quality of life dependent on care providers.
How can we enhance care of chronic patients such as PAH patients using digital technologies?
Improve Care
for chronic patients

Deadline: 20/12/2019
Challenge Owner

Eloi Torcal
Corporate product manager
Claudia Roca
Corporate marketing manager

Overview

Patients who suffer from severe chronic illnesses are often reliant on care givers in order to their maintain quality of life. This loss of freedom coupled with an already stressed care system in many parts of the world leads to a challenging life for many patients.

For example, PAH (Pulmonary Arterial Hypertension) patients currently have a bleak outlook as the disease is progressive and without cure. Patients live an average of 7-10 year from diagnosis and gradually see their mobility decreased. Patients eventually have to rely on continuous infusion pump therapy1 and are completely reliant on their support network (i.e. family members, doctors, nurses and physicians).

Challenge

How can we improve care, for chronic patients such as those suffering from advanced PAH symptoms and reduce the burden on their support network using digital solutions?

  1. Can we better track and monitor patients through a digitally enhanced solution?
  2. Can we provide guidance and troubleshoot common issues for patients digitally?
  3. Can we complement the patient support network, which is primarily face to face, though digital means?
  4. Can we help patients cope with pain and emotional distress using digital technologies?
  5. Can we reduce frequent patient visits to care centres for medicine collection and related tests?
1 Continuous pump therapy involves patients receiving a continuous dosage of drug(on a 24/7 basis) through a subcutaneous or implantable pump. Please click on each type to see an example.
Challenge 2
Improve patient engagement and adherence
Half of chronic patients suffering from silent cardiovascular diseases, such as coronary artery disease, diabetes, hypertension etc., do not take their prescribed medications.This results in more frequent and severe complications later in life.
How can we use digital technologies to improve patient engagement and medication adherence in these patients?
Improve patient engagement and adherence
Deadline: 20/12/2019
Challenge Owner

Carme Trepat
Head of Marketing

Overview

Half of the patients suffering from silent chronic cardiovascular diseases (CVD) stop taking their medication within 3 months of being diagnosed.1 The silent CVDs include coronary artery diseases, diabetes, cholesterol, hypertension and patients who are at an increased risk of heart attack and stoke (due to a previous event) and are now the leading cause of death.

In order for a person to take an action, three things need to happen first according to Dr. BJ Fogg (a psychologist and founder of Stanford Persuasive Technology Lab). First, the person needs to be motivated to perform the action. Second, the person needs to have the ability to perform that action. Finally, the person needs to have a trigger or a prompt which initiates the action2.

Most of the medical adherence solutions tend to focus on triggers through reminder applications etc. however the majority of non-adherence issues arise from lack of motivation or ability.

Challenge

How can we improve medication adherence using digital technologies for chronic patients suffering from silent CVDs so that they can live longer and healthier lives?

  1. Can we better motivate patients to adhere to medication?
  2. Can we increase the ability of patients to adhere to medication?
  3. Can we find novel and non intrusive ways to trigger people to take their medication?
1 Please refer to following article to learn more about medication adherence issues.
2Please refer to following article to learn more about BJ Fogg’s Behaviour Model.
Challenge 3
Reduce chronic
pain
Pain has an objective component (strength of signal to the brain) and a subjective component (how is the signal perceived).
How can we use digital technologies to better understand and treat both objective and subjective aspects of pain for chronic patients?
Manage chronic pain
Deadline: 20/12/2019
Challenge Owner

José Luís Lirio
Dir. U. Hospitals

Overview

Pain that a patient feels has two components: the objective component which is primarily the sensory response including the strength of signal sent to the brain and a subjective component which is a combination of cognitive, emotional and behavioural response that affects how the pain is perceived and reacted to. 1

The four responses (sensory, cognitive, emotional and behavioural) together create and modulate the intensity of pain felt by patients. Because pain is both physiological and psychological (i.e. psychophysiological) and hence personal to the individual, the current method of treatment which is somewhat generic and primarily focused on physiological aspects (i.e. sensory response) leaves a lot of room for improvement.

Challenge

How can we help patients suffering from chronic pain using digital solutions that enable them to have a better quality of life?

  1. Can we find a better and more objective way for patients to communicate the intensity of pain felt with doctors? Use cases: regular clinical practice, clinical trials, etc.
  2. Can we deliver targeted pain therapies digitally to patients leveraging one or more of the four responses above to reduce pain and dependence on drugs?
  3. Can we help patients, doctors and caregivers better track and monitor pain using digital technologies?
  4. Can we leverage digital technologies to build more connected pain therapy devices? Example: TENS 2
1 Please read this article by Eric L Garland to learn more about how pain is processed by us. 2 TENS is short for Transcutaneous Electrical Nerve Stimulation which use s electric current (low intensity) through a small hand held device to treat neuropathic pain.
Improve Care
for chronic patients

Deadline: 20/12/2019
Challenge Owner

Eloi Torcal
Corporate product manager
Claudia Roca
Corporate marketing manager

Overview

Patients who suffer from severe chronic illnesses are often reliant on care givers in order to their maintain quality of life. This loss of freedom coupled with an already stressed care system in many parts of the world leads to a challenging life for many patients.

For example, PAH (Pulmonary Arterial Hypertension) patients currently have a bleak outlook as the disease is progressive and without cure. Patients live an average of 7-10 year from diagnosis and gradually see their mobility decreased. Patients eventually have to rely on continuous infusion pump therapy1 and are completely reliant on their support network (i.e. family members, doctors, nurses and physicians).

Challenge

How can we improve care, for chronic patients such as those suffering from advanced PAH symptoms and reduce the burden on their support network using digital solutions?

  1. Can we better track and monitor patients through a digitally enhanced solution?
  2. Can we provide guidance and troubleshoot common issues for patients digitally?
  3. Can we complement the patient support network, which is primarily face to face, though digital means?
  4. Can we help patients cope with pain and emotional distress using digital technologies?
  5. Can we reduce frequent patient visits to care centres for medicine collection and related tests?
1 Continuous pump therapy involves patients receiving a continuous dosage of drug(on a 24/7 basis) through a subcutaneous or implantable pump. Please click on each type to see an example.
Improve patient engagement and adherence
Deadline: 20/12/2019
Challenge Owner

Carme Trepat
Head of Marketing

Overview

Half of the patients suffering from silent chronic cardiovascular diseases (CVD) stop taking their medication within 3 months of being diagnosed.1 The silent CVDs include coronary artery diseases, diabetes, cholesterol, hypertension and patients who are at an increased risk of heart attack and stoke (due to a previous event) and are now the leading cause of death.

In order for a person to take an action, three things need to happen first according to Dr. BJ Fogg (a psychologist and founder of Stanford Persuasive Technology Lab). First, the person needs to be motivated to perform the action. Second, the person needs to have the ability to perform that action. Finally, the person needs to have a trigger or a prompt which initiates the action2.

Most of the medical adherence solutions tend to focus on triggers through reminder applications etc. however the majority of non-adherence issues arise from lack of motivation or ability.

Challenge

How can we improve medication adherence using digital technologies for chronic patients suffering from silent CVDs so that they can live longer and healthier lives?

  1. Can we better motivate patients to adhere to medication?
  2. Can we increase the ability of patients to adhere to medication?
  3. Can we find novel and non intrusive ways to trigger people to take their medication?
1 Please refer to following article to learn more about medication adherence issues.
2Please refer to following article to learn more about BJ Fogg’s Behaviour Model.
Manage chronic pain
Deadline: 20/12/2019
Challenge Owner

José Luís Lirio
Dir. U. Hospitals

Overview

Pain that a patient feels has two components: the objective component which is primarily the sensory response including the strength of signal sent to the brain and a subjective component which is a combination of cognitive, emotional and behavioural response that affects how the pain is perceived and reacted to. 1

The four responses (sensory, cognitive, emotional and behavioural) together create and modulate the intensity of pain felt by patients. Because pain is both physiological and psychological (i.e. psychophysiological) and hence personal to the individual, the current method of treatment which is somewhat generic and primarily focused on physiological aspects (i.e. sensory response) leaves a lot of room for improvement.

Challenge

How can we help patients suffering from chronic pain using digital solutions that enable them to have a better quality of life?

  1. Can we find a better and more objective way for patients to communicate the intensity of pain felt with doctors? Use cases: regular clinical practice, clinical trials, etc.
  2. Can we deliver targeted pain therapies digitally to patients leveraging one or more of the four responses above to reduce pain and dependence on drugs?
  3. Can we help patients, doctors and caregivers better track and monitor pain using digital technologies?
  4. Can we leverage digital technologies to build more connected pain therapy devices? Example: TENS 2
1 Please read this article by Eric L Garland to learn more about how pain is processed by us. 2 TENS is short for Transcutaneous Electrical Nerve Stimulation which use s electric current (low intensity) through a small hand held device to treat neuropathic pain.
One file only.
10 MB limit.
Allowed types: txt pdf ppt pptx.

CONTROLLER Grupo Ferrer Internacional, S.A. with address at Av. Diagonal 549, 5th Floor, 08029, Barcelona (Spain).
PURPOSE Management, evaluation and monitoring of your communication, inquiries and / or comments.
LEGAL BASE Correct management of your communication, inquiry or comment regarding our activities and according to our Legal Notice and/or Terms of Use.
RECIPIENTS Ferrer’s group companies in case your communication it is managed by any of them. You can find information regarding our group companies in our Privacy Policy.
RIGHTS Access, rectification, deletion, opposition, limitation of processing, portability and presentation of a claim before a supervisory authority.
ADDITIONAL INFORMATION You can consult the additional and detailed information on data protection in the following link.

Benefits

Mentorship

We train you and mentor you and give you access to members of Start-up Advisory Board.

Partnership

We will partner with you on an ad-hoc basis to help develop your solution and accelerate your growth.

[Empty]

Access

We will serve as a reference for you and introduce you to stakeholders and leaders in the health industry.

Investment

We will provide funding through equity investments on a case by case basis.

Program
at a Glance

Sign-up for a Challenge

If you think you have a novel solution to one of our challenges, please apply by clicking on the "Apply" button below and choosing the specific challenge

Send Proposal
If you think you have a novel solution to one of our challenges, please submit your proposed solution to us by the posted deadline in no more than 10 slides.

Initial Pitch
If shortlisted, you will be invited deliver an initial pitch to us, 5-10mins. We will evaluate you on five dimensions: need, competitive advantage, business model, team and compatibility with Ferrer.

Final Pitch
If successful, we will give you a chance to present your solution to our panel of experts in a final pitch, 1 hour. We will evaluate you on the five dimensions in greater depth as well as explore how F4F program can be adapted to your needs.

Prizes / Work with us
If we foresee a potential for collaboration, we will formally invite you to enrol into F4F program with ad hoc content and duration (3 to 18 months)

Expected overall duration of steps 1 through 4 -> 3 months

img
Collaborate with us

If you have a solution that doesn’t quite fit one of our challenges but would like to collaborate with us, we’d love to hear from you. Please tell us about your proposal by clicking the Collaborate With Us button and we will engage in conversation to learn more.

Start-up
Advisory
Board

Start-up Advisory Board (SAB) is a group of individuals across Ferrer who are passionate about entrepreneurship, disruption and societal wellbeing. They have significant experience and knowledge in their field of expertise and are here to help you reach your goals.

Marta Anglada

Marta Anglada

Green Economy and Corporate Sustainability manager
Maria José Salvador

Maria José Salvador

Regional Business Director-Central America
Josep Miquel Sanchez Toll

Josep Miquel Sanchez Toll

Corporate Strategy Readiness Manager
Gerard  Oliveras

Gerard Oliveras

Área Manager
Ignacio Soldevila

Ignacio Soldevila

International Project Manager
Olga Fidalgo González

Olga Fidalgo González

Chief Officer R&D, BD&L, Medical Affairs
Guillem Florit

Guillem Florit

Head of Licensing In
Carlos López Borgoñoz

Carlos López Borgoñoz

International Marketing Director
David Puibert

David Puibert

Clinical Development
Anshul Gupta

Anshul Gupta

F4F consultant
David Martorell

David Martorell

Regional Senior Manager
Luca  Caruso

Luca Caruso

F4F consultant
Óscar Pérez

Óscar Pérez

Chief Marketing Officer
Ines Vergara

Ines Vergara

Senior Legal Counsel
Cristina Ruscalleda

Cristina Ruscalleda

Dir. Procurement, PMO and Sustainability
Marta Grifol

Marta Grifol

Head Business Development and Licensing
Isaac Treviño

Isaac Treviño

IT consultant
Mariano Martinez

Mariano Martinez

International Marketing Manager
Joan Ignasi Feixas

Joan Ignasi Feixas

Regional Senior Manager
Cristina Solá

Cristina Solá

Regulatory Affairs Manager
Eduardo Yanovsky

Eduardo Yanovsky

International Marketing Manager
Gemma Estrada Bertran

Gemma Estrada Bertran

Head Digital Health
Maria José Fuster Giner

Maria José Fuster Giner

Industrialization Manager
Nerea Blanqué Catalina

Nerea Blanqué Catalina

Director Market Access & Pricing
Mona Christina	Johansson

Mona Christina Johansson

Head of Project & Alliance Development
Georgina Marjanet

Georgina Marjanet

IP Counsel
Olga	Fidalgo

Olga Fidalgo

Chief Officer R&D, BD&L, Medical Affairs
Managing Director Spain

Ricardo Castrillo Pelaz

Managing Director Spain
Javier Inglés

Javier Inglés

Sales Area Manager
Alfredo Fernández Santín

Alfredo Fernández Santín

IP Head
Fabiana D’Aniello

Fabiana D’Aniello

Innovation Management Director
Silvia Ramírez

Silvia Ramírez

Innovation Manager
International Project Manager

Marc Comas

Marc Comas
Beatriz Gil

Beatriz Gil

Talent Specialist
Helen Birgit Nierhaus

Helen Birgit Nierhaus

Head Licensing Out & Alliance Manager
Gabriel Rubio

Gabriel Rubio

Global Market Access Manager
Ana Aliaga Gílpérez

Ana Aliaga Gílpérez

Corporate Director Business Development & Licensing
Silvia Ramírez

Silvia Baques Massó

Talent & Culture
Ricardo  Castrillo

Ricardo Castrillo

Managing Director Spain
David Ferrando

David Ferrando

Corporate Strategy Analysis Director
Maria Junyent

Maria Junyent

HR Business Partner
Marta Grifol

Marta Grifol

Head Business Development and Licensing
Nuria Albareda

Nuria Albareda

Global Clinical Project Lead
Francisco Amorin

Francisco Amorin

https://www.linkedin.com/in/franciscoamorin/?originalSubdomain=es
Gorka Ortiz de Zárate

Gorka Ortiz de Zárate

External Communication

Eventos

img

Barcelona Health Hub

3rd October 2019

We launched the F4F program at the beautiful Art Nouveau site of Hospital de Sant Pau in Barcelona where we hosted meetings with entrepreneurs.

img

Barcelona Tech City

5th November 2019

We discussed Ferrer's challenges with entrepreneurs at Pier 01, leading Digital Hub in Barcelona.

img

Frontiers Health

13th-15th November 2019

We presented F4F program to the international entrepreneurs, investors, and media attending the Berlin-based conference.

img IQS 4YFN
img
img
img

Contact Us

CONTROLLER Grupo Ferrer Internacional, S.A. with address at Av. Diagonal 549, 5th Floor, 08029, Barcelona (Spain).
PURPOSE Management, evaluation and monitoring of your communication, inquiries and / or comments.
LEGAL BASE Correct management of your communication, inquiry or comment regarding our activities and according to our Legal Notice and/or Terms of Use.
RECIPIENTS Ferrer’s group companies in case your communication it is managed by any of them. You can find information regarding our group companies in our Privacy Policy.
RIGHTS Access, rectification, deletion, opposition, limitation of processing, portability and presentation of a claim before a supervisory authority.
ADDITIONAL INFORMATION You can consult the additional and detailed information on data protection in the following link.

FAQ

How to apply for a challenge?
Go to the Challenge page and click on the “Apply” button for each individual challenge that you wish to apply. In case that your solution does not quite solve any of the challenges but you would like to collaborate with us, we are curious to hear from you. Please click on the “Collaborate with us “ button and send us your message.
Who can apply for challenges?
We invite entrepreneurs and businesses from all stages to apply for challenges. However, as we look for concrete solutions, the start-ups we work with tend to have a working minimum viable product or prototype.
Can I apply to more than one challenge?
Yes, you may apply to as many challenges as you wish.
What is the criteria for selection?
We evaluate your solution on five key areas: does your solution address a verified need, is your solution unique or has a clear competitive edge over other solutions, is the business model suitable, sustainable and scalable, does the team have the right experience, motivation and capabilities, and finally, the degree of compatibility with Ferrer.
How can I learn more about Ferrer 4 Future program?
Click on Contact Us above and send us your query or meet us at one of the events such as Barcelona Health Hub Summit in Barcelona or Frontiers Health conference in Berlin etc.
How many start-ups will be part of the program?
There is no fixed number of start-ups who will be part of the program. We will evaluate the solutions based on merit and whether there is an opportunity for collaboration.
What will happen to challenge winners?
Challenge winners will win prizes and will be invited to enroll into Ferrer for future program.
Who will finance my trips and stays in X city or Y country?
We do not sponsor trips/ stays. As such, you will be responsible for your own expenses associated with challenges and pitches.
How to apply for collaboration outside of challenges?
Click on Contact Us above or Collaborate With Us button to send us your details. Please also indicate the collaboration area you’re interested in when contacting us. Our active therapeutic areas of interest are Pain, Central Nervous System, Cardio-metabolism, Dermatology, Gynaecology, Gastro-intestinal and Oncology.
Are you open for collaboration in areas other than Central Nervous System, Cardio-metabolism, and Pain?
Yes, we are interested in collaborating in all therapeutic areas. We are also focused on, Dermatology, Gynaecology, Gastro-intestinal or Oncology related therapeutic areas and others.
How long will the collaboration last?
The collaboration timeline depends on multiple factors such as your solution, pace of development, internal and external influences & hurdles. However, you consider that we are looking for long term collaboration partners to disrupt digital health.
Is Ferrer 4 Future a venture fund/ arm of Ferrer?
No, Ferrer 4 Future is not a venture fund. Ferrer 4 future is a collaboration platform between us and the start-ups. We are interested in solutions that we can collaborate on to disrupt or build capabilities in digital health instead of solely returns. However, funds for investment will be available on a case by case basis as required.
Whom can I contact if I have more questions?
Click on Contact Us above and send us your query.
What to do if I have an IT issue?
Click on Contact Us above and tell about the issue.